Vivoz Biolabs
New York
About Vivoz Biolabs
Vivoz Biolabs develops cell culture platforms that are designed to mimic the dynamic 3D tumor microenvironment. The company aims to commercialize its layered microfluidic tissue assay, a patented technology that can be used as an ex vivo platform for drug screening and diagnosis, and a device for personalized cancer treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $224.7K
- Last round: Grant (Dec 2019)
- Website: vivozbiolabs.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/vivoz-biolabs-144910 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.